These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 22868372)

  • 21. [Study on miR-490-5p and miR-363 as novel biomarkers for the diagnosis of colorectal cancer].
    Xu X; Wu X; Wu S; Jiang Q; Liu H; Chen R; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):45-50. PubMed ID: 24519049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.
    Giráldez MD; Lozano JJ; Ramírez G; Hijona E; Bujanda L; Castells A; Gironella M
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):681-8.e3. PubMed ID: 23267864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
    Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
    Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
    Tokarz P; Blasiak J
    Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased serum miR-181a is a potential new tool for breast cancer screening.
    Guo LJ; Zhang QY
    Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer.
    Chen WS; Leung CM; Pan HW; Hu LY; Li SC; Ho MR; Tsai KW
    Oncol Rep; 2012 Sep; 28(3):1069-76. PubMed ID: 22766685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
    Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
    Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
    Ramzy I; Hasaballah M; Marzaban R; Shaker O; Soliman ZA
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):508-15. PubMed ID: 25736690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
    Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival.
    Silva J; García V; Zaballos Á; Provencio M; Lombardía L; Almonacid L; García JM; Domínguez G; Peña C; Diaz R; Herrera M; Varela A; Bonilla F
    Eur Respir J; 2011 Mar; 37(3):617-23. PubMed ID: 20595154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer.
    Liu Y; Zhou Y; Feng X; Yang P; Yang J; An P; Wang H; Ye S; Yu C; He Y; Luo H
    Genes Chromosomes Cancer; 2014 Apr; 53(4):358-65. PubMed ID: 24532280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy.
    Zhang J; Zhang K; Bi M; Jiao X; Zhang D; Dong Q
    Anticancer Drugs; 2014 Mar; 25(3):346-52. PubMed ID: 24304648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
    Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury.
    Lorenzen JM; Kielstein JT; Hafer C; Gupta SK; Kümpers P; Faulhaber-Walter R; Haller H; Fliser D; Thum T
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1540-6. PubMed ID: 21700819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.